Skip to main content
. 2017 Jan 17;8(7):12259–12271. doi: 10.18632/oncotarget.14696

Table 3. Primary Antibodies for IHC.

Primary Antibody Nation Company Working Concentration
PIWIL2 UK Novocastra 1:800
VIMENTIN UK Novocastra 1:800
SYN UK Novocastra 1:400
NESTIN UK Novocastra 1:800
PLAP Denmark Dako 1:200
CK UK Novocastra 1:1000
DES UK Novocastra 1:800
AFP China Gene Tech 1:400
SMA UK Novocastra 1:800
EMA UK Novocastra 1:600
MYOD1 UK Novocastra 1:100
CGA UK Novocastra 1:400
LCA Denmark Dako Working Solution